How is relapsed hairy cell leukemia treated?

Updated: Jan 16, 2019
  • Author: Sandy D Kotiah, MD; Chief Editor: Emmanuel C Besa, MD  more...
  • Print


Patients may relapse after initial treatment, so it is important to administer a second cycle of treatment as that can lead to another remission.

Although pentostatin and cladribine provide responses in greater than 85% of patients, and a median progression-free survival of up to 15 years, alternative treatments (eg, the addition of rituximab [15] ) are needed for patients whose disease becomes refractory to these treatments.

Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!